Current Trends in Antibody Drug Conjugates (ADCs) Characterization: Expert PaperCurrent Trends in Antibody Drug Conjugates (ADCs) Characterization: Expert Paper

BPI Contributor

June 14, 2022

1 Min Read
Current Trends in Antibody Drug Conjugates (ADCs) Characterization: Expert Paper

Already have an account?

We bring you a brand-new paper focused on Current Trends in Antibody Drug Conjugates Characterization, focusing on structure.

Comprehensive structural, biophysical, and physico-chemical property characterization in alignment with Chemistry, Manufacturing and Controls (CMC) guidance is a requirement to achieve successful regulatory (IND) submissions. Multiple analytical technologies are required for ADC analysis with a focus on the drug’s critical quality attributes (CQA), with data interpretation conducted by experienced biopharmaceutical analytical scientists. In this review, we discuss the current trends in antibody drug conjugates characterization, and more.


Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.

You May Also Like